Form 8-K - Current report:
SEC Accession No. 0001655759-25-000004
Filing Date
2025-01-10
Accepted
2025-01-10 08:50:06
Documents
18
Period of Report
2025-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20250110.htm   iXBRL 8-K 35903
2 EX-99.1 a2025-01x10xjpmcorporate.htm EX-99.1 13068
6 a2025-01x10xjpmcorporate001.jpg GRAPHIC 222396
7 a2025-01x10xjpmcorporate002.jpg GRAPHIC 216384
8 a2025-01x10xjpmcorporate003.jpg GRAPHIC 281173
9 a2025-01x10xjpmcorporate004.jpg GRAPHIC 127124
  Complete submission text file 0001655759-25-000004.txt   1353340

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250110.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250110_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250110_pre.xml EX-101.PRE 13581
20 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250110_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 25520647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)